Show simple item record

dc.contributor.authorHobbelink, SMR
dc.contributor.authorBrockley, CR
dc.contributor.authorKennedy, RA
dc.contributor.authorCarroll, K
dc.contributor.authorde Valle, K
dc.contributor.authorRao, P
dc.contributor.authorDavis, MR
dc.contributor.authorLaing, NG
dc.contributor.authorVoermans, NC
dc.contributor.authorRyan, MM
dc.contributor.authorYiu, EM
dc.date.accessioned2020-12-09T23:22:33Z
dc.date.available2020-12-09T23:22:33Z
dc.date.issued2018-04-01
dc.identifierpii: BRB3919
dc.identifier.citationHobbelink, S. M. R., Brockley, C. R., Kennedy, R. A., Carroll, K., de Valle, K., Rao, P., Davis, M. R., Laing, N. G., Voermans, N. C., Ryan, M. M. & Yiu, E. M. (2018). Dejerine-Sottas disease in childhood-Genetic and sonographic heterogeneity. BRAIN AND BEHAVIOR, 8 (4), https://doi.org/10.1002/brb3.919.
dc.identifier.issn2162-3279
dc.identifier.urihttp://hdl.handle.net/11343/253205
dc.description.abstractIntroduction: The nerve sonographic features of Dejerine-Sottas disease (DSD) have not previously been described. Methods: This exploratory cross-sectional, matched, case-control study investigated differences in nerve cross-sectional area (CSA) in children with DSD compared to healthy controls and children with Charcot-Marie-Tooth disease type 1A (CMT1A). CSA of the median, ulnar, tibial, and sural nerves was measured by peripheral nerve ultrasound. The mean difference in CSA between children with DSD, controls, and CMT1A was determined individually and within each group. Results: Five children with DSD and five age- and sex-matched controls were enrolled. Data from five age-matched children with CMT1A was also included. Group comparison showed no mean difference in nerve CSA between children with DSD and controls. Individual analysis of each DSD patient with their matched control indicated an increase in nerve CSA in three of the five children. The largest increase was observed in a child with a heterozygous PMP22 point mutation (nerve CSA fivefold larger than a control and twofold larger than a child with CMT1A). Nerve CSA was moderately increased in two children-one with a heterozygous mutation in MPZ and the other of unknown genetic etiology. Conclusions: Changes in nerve CSA on ultrasonography in children with DSD differ according to the underlying genetic etiology, confirming the variation in underlying pathobiologic processes and downstream morphological abnormalities of DSD subtypes. Nerve ultrasound may assist in the clinical phenotyping of DSD and act as an adjunct to known distinctive clinical and neurophysiologic findings of DSD subtypes. Larger studies in DSD cohorts are required to confirm these findings.
dc.languageEnglish
dc.publisherWILEY
dc.rights.urihttps://creativecommons.org/licenses/by/4.0
dc.titleDejerine-Sottas disease in childhood-Genetic and sonographic heterogeneity
dc.typeJournal Article
dc.identifier.doi10.1002/brb3.919
melbourne.affiliation.departmentPaediatrics (RCH)
melbourne.source.titleBrain and Behavior
melbourne.source.volume8
melbourne.source.issue4
dc.rights.licenseCC BY
melbourne.elementsid1307153
melbourne.contributor.authorRyan, Monique
melbourne.contributor.authorYiu, Eppie
dc.identifier.eissn2162-3279
melbourne.accessrightsOpen Access


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record